ISTH 2021 Congress
Coagulation and Natural Anticoagulants » Coagulation Factors and Inhibitors
Theme Navigation
- ISTH 2021 Congress
- Coagulation and Natural Anticoagulants
- Coagulation Factors and Inhibitors
- Coagulation and Natural Anticoagulants
-
Abstract Number: PB0057
Ex vivo Evaluation of the Effect of Plasma-derived Factor VIII/von Willebrand Factor in Patients with Severe Hemophilia A on Prophylaxis with Emicizumab by ROTEM
-
Abstract Number: OC 05.3
A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs
-
Abstract Number: OC 27.4
A Unique Loop Structure in the A2-domain of Pseudonaja textilis Factor Va Prevents Activated Protein C-catalyzed A2-domain Dissociation
-
Abstract Number: LB 01.2
Abelacimab for Prevention of Venous Thromboembolism
-
Abstract Number: PB0072
Analysis of Coagulation Factors in Fresh-frozen Plasma
-
Abstract Number: PB0058
Are Direct Oral Anti-Xa Inhibitors Absorbed in Cancer Patients after Gastrectomy? A Case Series
-
Abstract Number: PB0051
Combining Heparin with a FX/FXa Aptamer to Reduce Thrombin Generation in Models of Cardiopulmonary Bypass and COVID-19 Associated Coagulopathy
-
Abstract Number: PB0047
Comparing the Real-world and Clinical Trial Bleeding Rates Associated with Anticoagulation Treatment for Atrial Fibrillation
-
Abstract Number: PB0045
D-dimer and the Risk of Diabetes: The REasons for Geographic and Racial Differences in Stroke (REGARDS)
-
Abstract Number: OC 43.1
Deep Mutational Scan of the VWF C Domains to Define Mutations Associated with VWD
-
Abstract Number: OC 14.3
Development of Monoclonal Antibodies that Protect FV/FVa from APC-mediated Inactivation for the Treatment of Bleeding
-
Abstract Number: OC 60.4
Discovery and in vitro Characterization of an Antibody Fragment (Fab) which Neutralizes Milvexian (BMS-986177/JNJ-70033093)
-
Abstract Number: PB0067
Evaluation and Performance Characteristics of the Automated Sysmex CN-6000 Haemostasis Analyzer
-
Abstract Number: PB0052
Evaluation of a New Thromboplastin Reagent Containing Human Recombinant Tissue Factor for the Determination of Prothrombin Time Reagent: the (h)PT-Phen™ LRT
-
Abstract Number: OC 05.4
Evolutionary Adaptation of the Gamma-carboxyglutamic Acid Domain in Venom Factor X from the Australian Common Brown Snake
-
Abstract Number: PB0044
Factor XIa Inhibitor Milvexian (BMS-986177/JNJ-70033093) Suppresses Plasma Clot Formation and Reduces Resistance to Fibrinolysis in vitro
-
Abstract Number: OC 05.2
Fluorescence Correlation Spectroscopy Provides New Insights into the Mechanism of Prothrombin Recognition by the Prothrombinase Complex
-
Abstract Number: PB0038
Generation of Anticoagulant RNA Aptamers Targeting Cofactors that Inhibit Clotting in Normal and COVID-19 Patient Samples
-
Abstract Number: PB0055
HemosIL Liquid Anti-Xa Apixaban Measurement in Patients with High Risk of Major Bleeding
-
Abstract Number: PO121
Hemostatic Defects Associated with IgA Monoclonal Gammopathy